Abstract

Get full access to this article
View all access options for this article.
References
1.
Costescu
D
Guilbert
E
Bernardin
J
et al
. Medical abortion . J Obstet Gynaecol Can 2016 ;38 (4 ):366-89.
2.
Norman
WV.
Induced abortion in Canada 1974-2005: trends over the first generation with legal access . Contraception 2012 ;85 :185-91.
3.Government of Canada . Recalls and safety alerts. Mifepristone and misoprostol tablets: updates to product monograph and risk management plan . Available: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2017/65030a-eng.php. (accessed Aug. 2, 2018 ).
4.
Jones
RK
Henshaw
SK.
Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden . Perspect Sex Reprod Health 2002 ;34 :154-61.
5.Medical abortion . In: Compendium of therapeutics for minor ailments . Ottawa (ON) : Canadian Pharmacists Association . Available: www.e-therapeutics.ca (accessed Aug. 2, 2018 ).
6.Canadian Abortion Providers Support . Medical abortion charting form . Available: https://www.caps-cpca.ubc.ca/AnnokiUploadAuth.php/e/e0/Canadian_Resource_1_-_Medical_Abortion_Prescriber_Checklist_2018-07-11.pdf (accessed Aug. 2, 2018 ).
7.
Soon
J
Costescu
D
Guilbert
E.
Medications used in evidence-based regimens for medical abortion an overview . J Obstet Gynaecol Can 2016 ;38 (7 ):636-45.
8.Sexual Health Options Resources Education (SHORE) Centre . Abortion pill . Available: https://www.shorecentre.ca/pill/ (accessed Aug. 2, 2018 ).
